Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1982 Sep;22(3):409–413. doi: 10.1128/aac.22.3.409

Comparison of cefuroxime and penicillin in the treatment of uncomplicated gonorrhea.

J G Lossick, S E Thompson, M P Smeltzer
PMCID: PMC183758  PMID: 6814355

Abstract

In a randomized double-blind trial, 216 men and 142 women infected with uncomplicated gonorrhea were treated with either 1.5 g of cefuroxime or 4.8 x 10(6) U of aqueous procaine penicillin G intramuscularly and 1.0 g of probenecid. The cure rates in the treatment groups were 96 and 95%, respectively. Intramuscularly administered cefuroxime was better tolerated than was procaine penicillin. Comparative antibiotic susceptibility studies revealed that cefuroxime and penicillin were about equally active and that both were more active than cefamandole or cefoxitin. Because cefuroxime is not degraded by the action of beta-lactamase enzymes, it has promise as an alternative to spectinomycin in the treatment of penicillinase-producing Neisseria gonorrhoeae infections.

Full text

PDF
409

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Fowler W., Rahim G., Brown J. D. Clinical experience in the use of cefuroxime in gonorrhoea. Br J Vener Dis. 1978 Dec;54(6):400–402. doi: 10.1136/sti.54.6.400. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Gomme L. Cefuroxime treatment of patients with lower respiratory and urinary tract infections. Proc R Soc Med. 1977;70(Suppl 9):82–85. doi: 10.1177/00359157770700S916. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Handsfield H. H., Knapp J. S., Diehr P. K., Holmes K. K. Correlation of auxotype and penicillin susceptibility of Neisseria gonorrhoeae with sexual preference and clinical manifestations of gonorrhea. Sex Transm Dis. 1980 Jan-Mar;7(1):1–5. doi: 10.1097/00007435-198001000-00001. [DOI] [PubMed] [Google Scholar]
  4. Hänninen P., Saarimaa H., Toivanen P., Kasanen A. Clinical profile of cefuroxime in sixty-four patients. Proc R Soc Med. 1977;70(Suppl 9):111–117. doi: 10.1177/00359157770700S925. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Jaffe H. W., Biddle J. W., Johnson S. R., Wiesner P. J. Infections due to penicillinase-producing Neisseria gonorrhoeae in the United States: 1976-1980. J Infect Dis. 1981 Aug;144(2):191–197. doi: 10.1093/infdis/144.2.191. [DOI] [PubMed] [Google Scholar]
  6. Jaffe H. W., Biddle J. W., Thornsberry C., Johnson R. E., Kaufman R. E., Reynolds G. H., Wiesner P. J. National gonorrhea therapy monitoring study: in vitro antibiotic susceptibility and its correlation with treatment results. N Engl J Med. 1976 Jan 1;294(1):5–9. doi: 10.1056/NEJM197601012940102. [DOI] [PubMed] [Google Scholar]
  7. Morrison G. D., Evans A. J., Haskins H. W., Lewis N. M., Seale G. H., Mayall E., Mullinger B. M. Cefuroxime compared with penicillin for the treatment of gonorrhea. Sex Transm Dis. 1980 Oct-Dec;7(4):188–190. doi: 10.1097/00007435-198010000-00009. [DOI] [PubMed] [Google Scholar]
  8. Norrby R., Foord R. D., Price J. D., Hedlund P. Pharmacokinetic and clinical studies on cefuroxime. Proc R Soc Med. 1977;70(Suppl 9):25–33. doi: 10.1177/00359157770700S906. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. O'Callaghan C. H., Morris A., Kirby S. M., Shingler A. H. Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate. Antimicrob Agents Chemother. 1972 Apr;1(4):283–288. doi: 10.1128/aac.1.4.283. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Phillips I., King A., Warren C., Watts B. The activity of penicillin and eight cephalosporins on Neisseria gonorrhoeae. J Antimicrob Chemother. 1976 Mar;2(1):31–39. doi: 10.1093/jac/2.1.31. [DOI] [PubMed] [Google Scholar]
  11. Phillips I., Shannon K. The activity of cephalosporins on beta-lactamase-producing Neisseria gonorrhoeae. Scand J Infect Dis Suppl. 1978;(13):23–26. [PubMed] [Google Scholar]
  12. Price J. D., Fluker J. L. The efficacy of cefuroxime for the treatment of acute gonorrhoea in men. Br J Vener Dis. 1978 Jun;54(3):165–167. doi: 10.1136/sti.54.3.165. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Sherman K. E., Dodd R. Y. Alanine aminotransferase levels among volunteer blood donors: geographic variation and risk factors. J Infect Dis. 1982 Mar;145(3):383–386. doi: 10.1093/infdis/145.3.383. [DOI] [PubMed] [Google Scholar]
  14. Svensson R. Clinical evaluation of cefuroxime. Proc R Soc Med. 1977;70(Suppl 9):98–100. doi: 10.1177/00359157770700S921. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Thornsberry C., Biddle J. W., Perine P. L., Siegel M. In vitroSusceptibility of β-Lactamase Positive and β-Lactamase Negative Strains ofNeisseria gonorrhœœto Cefuroxime. Proc R Soc Med. 1977;70(Suppl 9):122–124. doi: 10.1177/00359157770700S927. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES